Dashboard
Manage Tickers

QDELQUIDEL CORP /DE/

Nasdaq www.quidel.com


$ 44.66 $ -0.35 (-0.78 %)    

Monday, 26-Aug-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.80 $ -5.13 (-1.07 %)
DIA $ 412.48 $ 0.65 (0.16 %)
SPY $ 560.78 $ -1.35 (-0.24 %)
TLT $ 98.13 $ -0.26 (-0.26 %)
GLD $ 232.75 $ 0.73 (0.31 %)
$ 45.01
$ 45.22
$ 44.62 x 100
$ 44.66 x 100
$ 44.30 - $ 45.22
$ 29.74 - $ 84.60
616,121
na
1.88B
$ 0.21
$ 1.87
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-04-2022 03-31-2022 10-Q
2 02-18-2022 12-31-2021 10-K
3 11-04-2021 09-30-2021 10-Q
4 08-05-2021 06-30-2021 10-Q
5 05-07-2021 03-31-2021 10-Q
6 02-19-2021 12-31-2020 10-K
7 10-30-2020 09-30-2020 10-Q
8 07-31-2020 06-30-2020 10-Q
9 05-07-2020 03-31-2020 10-Q
10 02-13-2020 12-31-2019 10-K
11 10-31-2019 09-30-2019 10-Q
12 08-09-2019 06-30-2019 10-Q
13 05-09-2019 03-31-2019 10-Q
14 02-15-2019 12-31-2018 10-K
15 11-07-2018 09-30-2018 10-Q
16 08-08-2018 06-30-2018 10-Q
17 05-09-2018 03-31-2018 10-Q
18 02-27-2018 12-31-2017 10-K
19 11-02-2017 09-30-2017 10-Q
20 07-27-2017 06-30-2017 10-Q
21 04-27-2017 03-31-2017 10-Q
22 02-16-2017 12-31-2016 10-K
23 10-28-2016 09-30-2016 10-Q
24 07-28-2016 06-30-2016 10-Q
25 04-29-2016 03-31-2016 10-Q
26 02-23-2016 12-31-2015 10-K
27 10-29-2015 09-30-2015 10-Q
28 07-23-2015 06-30-2015 10-Q
29 04-24-2015 03-31-2015 10-Q
30 02-24-2015 12-31-2014 10-K
31 10-24-2014 09-30-2014 10-Q
32 07-24-2014 06-30-2014 10-Q
33 04-25-2014 03-31-2014 10-Q
34 02-27-2014 12-31-2013 10-K
35 10-25-2013 09-30-2013 10-Q
36 07-31-2013 06-30-2013 10-Q
37 04-24-2013 03-31-2013 10-Q
38 02-22-2013 12-31-2012 10-K
39 10-29-2012 09-30-2012 10-Q
40 07-27-2012 06-30-2012 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rbc-capital-reiterates-outperform-on-quidelortho-maintains-61-price-target
RBC Capital Reiterates Outperform on Quide...
08/16/2024 16:02:32

RBC Capital analyst Conor McNamara reiterates QuidelOrtho (NASDAQ:QDEL) with a Outperform and maintains $61 price target.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
08/08/2024 17:35:17

rbc-capital-reiterates-outperform-on-quidelortho-maintains-61-price-target
RBC Capital Reiterates Outperform on Quide...
08/01/2024 15:54:02

RBC Capital analyst Conor McNamara reiterates QuidelOrtho (NASDAQ:QDEL) with a Outperform and maintains $61 price target.

quidelortho-q2-2024-adj-eps-007-beats-023-estimate-sales-637000m-beat-613537m-estimate
QuidelOrtho Q2 2024 Adj. EPS $(0.07) Beats...
07/31/2024 20:13:52

QuidelOrtho (NASDAQ:QDEL) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.23) b...

att-group-1-automotive-mattel-seagate-and-other-big-stocks-moving-higher-on-wednesday
AT&T, Group 1 Automotive, Mattel, Seagate ...
07/24/2024 14:46:56

Core News & Articles
QuidelOrtho To Replace Hibbett In S&P Smal...
07/23/2024 21:19:28

JD Sports Fashion Plc (XLON: JD) is acquiring Hibbett in a deal expected to close soon pending final closing conditions. 

Core News & Articles
Avantor To Replace QuidelOrtho In The S&P ...
07/23/2024 21:18:19

activist-jana-partners-built-position-in-quidelortho-in-first-quarter
Activist Jana Partners Built Position In Q...
05/14/2024 16:55:05

- Reuters Citing Sources 

rbc-capital-maintains-outperform-on-quidelortho-lowers-price-target-to-68
RBC Capital Maintains Outperform on Quidel...
05/09/2024 17:08:00

RBC Capital analyst Conor McNamara maintains QuidelOrtho (NASDAQ:QDEL) with a Outperform and lowers the price target from $8...

quidelortho-q1-2024-adj-eps-044-beats-039-estimate-sales-711000m-beat-693244m-estimate
QuidelOrtho Q1 2024 Adj EPS $0.44 Beats $0...
05/08/2024 20:34:21

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.39 by ...

quidelortho-appoints-brian-blaser-as-president-and-ceo-effective-may-6
QuidelOrtho Appoints Brian Blaser As Presi...
05/02/2024 12:19:39

In addition to his appointment as President and CEO, Blaser will join the Board, effective May 15, 2024, when the Board will be...

quidelortho-adds-fentanyl-test-to-its-vitros-systems-as-a-microtip-partnership-assay-to-help-hospital-and-emergency-room-customers-allow-on-site-fentanyl-testing-in-less-than-10-minutes
QuidelOrtho Adds Fentanyl Test To Its Vitr...
04/10/2024 11:09:14

why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Stryve Foods Shares Are Trading Lower ...
04/02/2024 17:23:42

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

whats-going-with-covid-19-test-maker-quidelortho-stock-on-tuesday
What's Going With COVID-19 Test Maker Quid...
04/02/2024 17:05:36

QuidelOrtho secures FDA approval for QuickVue COVID-19 test, catering to home and medical settings. Despite Savanna RVP4+ assay...

rbc-out-with-note-on-quidelortho-saying-after-speaking-to-management-no-change-at-quidelortho-company-withdraws-original-savanna-rvp4-assay-from-fda-510k-submission-plans-resubmission-ahead-of-20242025-respiratory-season
RBC Out With Note On QuidelOrtho Saying "A...
04/02/2024 16:19:09

quidelortho-receives-fda-clearance-for-quickvue-covid-19-test
QuidelOrtho Receives FDA Clearance For Qui...
04/02/2024 13:01:08

Test Delivers on Company Commitment to Advance the Power of Diagnostics to Empower Patients with Rapid Results in Just 10 Minut...

quidelortho-receives-health-canada-approval-for-quidel-triage-plgf-test-for-laboratory-use-in-canada
QuidelOrtho Receives Health Canada Approva...
03/06/2024 21:50:56

analyst-scoreboard-6-ratings-for-quidelortho
Analyst Scoreboard: 6 Ratings For QuidelOrtho
03/04/2024 12:00:39

ubs-downgrades-quidelortho-to-sell-lowers-price-target-to-42
UBS Downgrades QuidelOrtho to Sell, Lowers...
03/04/2024 11:01:42

UBS analyst John Sourbeer downgrades QuidelOrtho (NASDAQ:QDEL) from Neutral to Sell and lowers the price target from $70 to ...

quidelorthos-board-of-directors-has-terminated-president-and-chief-executive-officer-douglas-bryant-and-appointed-on-an-interim-basis-michael-iskra-as-chief-executive-officer-and-robert-bujarski-as-president
QuidelOrtho's Board Of Directors Has Termi...
02/21/2024 12:46:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION